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Bves and NDRG4 regulate directional epicardial 
cell migration through autocrine extracellular 
matrix deposition
Emily C. Benesha,b, Paul M. Millera, Elise R. Pfaltzgraffa, Nathan E. Grega-Larsona, 
Hillary A. Hagera, Bong Hwan Sungc, Xianghu Qud, H. Scott Baldwind, Alissa M. Weaverc,e, 
and David M. Baderf
aDepartment of Cell and Developmental Biology, cDepartment of Cancer Biology, dDepartment of Pediatric 
Cardiology, eDepartment of Pathology, and fDepartment of Medicine, Division of Cardiovascular Medicine, Vanderbilt 
University School of Medicine, Nashville, TN 37232; bDepartment of Obstetrics and Gynecology, Washington 
University in St. Louis, St. Louis, MO 63110
ABSTRACT Directional cell movement is universally required for tissue morphogenesis. 
Although it is known that cell/matrix interactions are essential for directional movement in 
heart development, the mechanisms governing these interactions require elucidation. Here 
we demonstrate that a novel protein/protein interaction between blood vessel epicardial 
substance (Bves) and N-myc downstream regulated gene 4 (NDRG4) is critical for regulation 
of epicardial cell directional movement, as disruption of this interaction randomizes migratory 
patterns. Our studies show that Bves/NDRG4 interaction is required for trafficking of internal-
ized fibronectin through the “autocrine extracellular matrix (ECM) deposition” fibronectin re-
cycling pathway. Of importance, we demonstrate that Bves/NDRG4-mediated fibronectin re-
cycling is indeed essential for epicardial cell directional movement, thus linking these two cell 
processes. Finally, total internal reflectance fluorescence microscopy shows that Bves/NDRG4 
interaction is required for fusion of recycling endosomes with the basal cell surface, providing 
a molecular mechanism of motility substrate delivery that regulates cell directional movement. 
This is the first evidence of a molecular function for Bves and NDRG4 proteins within broader 
subcellular trafficking paradigms. These data identify novel regulators of a critical vesicle-
docking step required for autocrine ECM deposition and explain how Bves facilitates cell-
microenvironment interactions in the regulation of epicardial cell–directed movement.
INTRODUCTION
Blood vessel epicardial substance (Bves; or Popdc1), an integral 
membrane protein, is the prototypical member of the Popdc family, 
which regulates cell migration and adhesion through unknown 
molecular mechanisms. Bves shares a conserved cAMP-binding 
Popeye domain but contains no other homologous functional do-
mains with other protein families (Andrée et al., 2000; Froese et al., 
2012). First identified in epicardial tissue, Bves is now recognized for 
its dynamic distribution in a multitude of cell types (Reese et al., 
1999; Andrée et al., 2000; DiAngelo et al., 2001; Wada et al., 2001; 
Ripley et al., 2004; Vasavada et al., 2004; Smith and Bader, 2006; 
Kawaguchi et al., 2008; Russ et al., 2010). Disruption of Bves ran-
domizes and accelerates cell movement. For example, in normal 
Xenopus laevis development, individual A1 blastomeres, early em-
bryonic cells, give rise to progeny that migrate in a highly patterned 
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somes. These data provide a molecular mechanism for motility sub-
strate delivery that regulates directional cell movement. Taken to-
gether, they demonstrate that Bves, through interaction with its 
binding partners, is essential for cell surface fusion of endosomes in 
regulation of cell motility and adhesion. Given the diversity of phe-
notypes observed with Bves loss of function, the present study has 
broad implications for development, cancer, and repair.
RESULTS
Bves and NDRG4 bind directly through a novel interaction 
domain
In an effort to determine molecular function, were identified Bves 
binding partners with a split ubiquitin two-hybrid screen (Iyer et al., 
2005) designed for membrane-associated proteins using Bves as 
bait. Initial results identified a direct interaction between Bves and 
NDRG4 that passed all stringency selection tests (DualSystems, 
Biotech, Zurich, Switzerland). Myc-tagged full-length Bves (Bves-myc) 
coimmunoprecipitated with green fluorescent protein (GFP)–tagged 
NDRG4 (NDRG4-GFP) from Cos7 cell lysates, biochemically confirm-
ing the interaction identified by split ubiquitin screening technology 
(Figure 1A). To further define the interaction domain, we analyzed a 
series of glutathione S-transferase (GST)–tagged Bves constructs in 
which the C-terminus (GST-Bves357; amino acids 115–357) was suc-
cessively truncated (Figure 1B, left). Only the GST-Bves357 interacted 
with NDRG4 (Figure 1B, right). All other C-terminal truncations failed 
to pull down NDRG4-GFP. All Bves-GST truncations failed to interact 
with enhanced GFP expressed in Cos7 cell lysates (Figure 1B′). These 
data suggested that the NDRG4 binding domain was likely to be 
contained within the region between amino acids 300 and 357.
SPOTs analysis (as modified from Kawaguchi et al., 2008) was 
performed to determine the minimal Bves residues sufficient to in-
teract with NDRG4. Thirteen-mer peptides of BCT were fused to a 
cellulose membrane with 10–amino acid overlap between adjacent 
peptides (diagram in Figure 1C) and probed with Cos7 lysate en-
riched for NDRG4-GFP. NDRG4-GFP specifically bound to pep-
tides 63–65, which corresponded to residues 307–316 of the Bves 
protein (Figure 1C, bottom and overlay). Of importance, SPOTs 
analysis mirrored our truncation pull-down results, in which Bves/
NDRG4 interaction was observed only with inclusion of residues 
300–357 (Figure 1D). These data identify a novel protein–protein 
interaction site within the Bves C-terminus that is outside of the 
conserved Popeye domain. It is a region found only in Bves and not 
in Popdc2/3 (National Center for Biotechnology Information [www 
.ncbi.nlm.nih.gov/]; Popdc1/Bves [NP_077247.1]; Popdc2 isoforms 
1 and 2 [NP_001075453.1, NP_071713.1]; Popdc3 [NP_077248.1]). 
The newly identified Bves/NDRG4 minimal binding domain (Bv/
N4-MBD) was cloned into a Myc-tagged fusion vector (residues 
292–331 cloned into Myc-3tag vector; Figure 1D).
Bves and NDRG4 colocalize and interact in mammalian 
epicardial cells
Bves and NDRG4 gene products are both enriched in the develop-
ing heart tube (Qu et al., 2002; Hager and Bader, 2009). We exam-
ined the precise distribution patterns of the two proteins in E14.5 
cardiac tissue and determined that Bves and NDRG4 colocalized in 
both epicardial cells and cardiac myocytes (Figure 2A, epicardium in 
inset). Furthermore, coimmunoprecipitation of epicardial cell lysates 
demonstrated that an antibody to endogenous Bves pulls down 
both Bves and NDRG4 protein, whereas MF-20 antibody, an anti–
sarcomeric myosin heavy chain antibody (Bader et al., 1982) bound 
to beads, did not (Figure 2B). Given that subcellular localization of 
Bves varies depending on whether cells are freely migratory or 
manner, incorporating into anterior head and somitic structures. 
With morpholino knockdown of Bves in these same blastomeres, 
migration of resulting progeny is completely randomized, with cells 
moving throughout the embryo (Ripley et al., 2006). Randomization 
of movement after Bves loss of function is a recurring theme ob-
served in both single-cell and sheet epithelium migration models, 
including human corneal epithelial cells, germ cells of the fly, and 
myoblasts in murine skeletal muscle regeneration (Wada et al., 2001; 
Andrée et al., 2002; Ripley et al., 2004, 2006; Osler et al., 2005; Lin 
et al., 2007; Kawaguchi et al., 2008; Smith et al., 2008; Hager et al., 
2010; Kim et al., 2010). Bves function in regulation of cell movement 
is of immediate relevance, as Bves has recently been identified as a 
metastasis suppressor in colorectal cancers (Williams et al., 2011). 
Thus Bves is an important mediator of cell adhesion and movement 
in a variety of settings.
Although Bves has emerged as a strong regulator of cell move-
ment, the lack of identifiable motifs within the protein has made 
assignment of molecular functions challenging. To circumvent this 
problem, yeast two-hybrid interaction screens were conducted to 
identify binding partners and link Bves to a molecular function. Of 
importance, Hager et al. (2010) demonstrated that Bves interacts 
with the recycling endosome soluble N-ethylmaleimide–sensitive 
factor attachment protein receptor (SNARE) protein, vesicle-associ-
ated membrane protein 3 (VAMP3; cellubrevin), to facilitate traffick-
ing of two canonical VAMP3-dependent cargoes, transferrin and 
β1-integrin, to the cell surface. Previous work demonstrated that loss 
of Bves function disrupted subcellular localization of cell/cell adhe-
sion molecules such as E-cadherin and occludin (Osler et al., 2005; 
Russ et al., 2011). Thus we postulated that Bves serves as a pivotal 
regulator of subcellular trafficking of molecules to the cell surface. 
Still, understanding of the precise molecular behavior of Bves within 
subcellular trafficking pathways remains unresolved.
Here using multiple methodologies, we identify a novel interac-
tion between Bves and N-myc downstream regulated gene 4 
(NDRG4), which is of interest because NDRG4 influences cell behav-
iors regulated by Bves, including cell migration and process exten-
sion (Zhou et al., 2001; Qu et al., 2002, 2008; Nishimoto et al., 2003; 
Melotte et al., 2009; Schilling et al., 2009; Kim et al., 2010; Williams 
et al., 2011). Loss of NDRG4 in mouse models depletes intracere-
bral brain-derived neurotrophic factor through unknown mecha-
nisms, causing spatial learning defects in animals (Yamamoto et al., 
2011). Thus it is intriguing that the NDRG protein family has been 
generally implicated in trafficking of cell surface proteins (Ohki et al., 
2002; Okuda et al., 2004; Berger et al., 2006; Kachhap et al., 2007; 
Choi et al., 2010). Finally, NDRG4, like Bves, is a colorectal cancer 
tumor suppressor (Melotte et al., 2009). Owing to these functional 
similarities, the relationship between Bves and NDRG4 was ana-
lyzed in greater depth.
We demonstrate that Bves/NDRG4 protein function provides the 
molecular underpinning for two critical and previously unlinked cell 
behaviors in epicardial cells. First, our data determine that this inter-
action is essential for directional cell movement, as its disruption 
randomizes and accelerates cell migration. Next we demonstrate 
that Bves and NDRG4 regulate the deposition of internalized solu-
ble fibronectin for resecretion through the autocrine extracellular 
matrix (ECM) recycling pathway (Sung et al., 2011). Of importance, 
a series of cell/ECM recombination studies reveals that directional 
cell movement is, in fact, dependent on fibronectin recycling and 
that Bves/NDRG4 interaction is essential in linking these two pro-
cesses. Further, live-cell imaging using total internal reflectance flu-
orescence (TIRF) microscopy reveals that Bves/NDRG4 interaction 
mediates cell surface docking of VAMP3-positive recycling endo-
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failed to colocalize in established epicardial sheets (Figure 2E, inset). 
Here NDRG4 localization was primarily cytoplasmic, whereas Bves 
localized to the cell cortex and plasma membrane. Fluorescence 
was not apparent in secondary antibody-only negative controls, 
demonstrating that the signal was the result of anti-Bves and anti-
NDRG4 antibody activity (Supplemental Figure S1). Taken together, 
these data indicate that Bves and NDRG4 interact in epicardial cells. 
Colocalization in cells of motile morphology suggests that Bves and 
NDRG4 function in a capacity related to cell migration.
within epithelial sheets (Wada et al., 2001; Osler et al., 2005), we 
examined the subcellular localization of Bves and NDRG4 under 
varied epicardial cellular conditions. Epicardial cells at low conflu-
ence are motile, with a mesenchymal morphology (Wada et al., 
2003). In this setting, Bves and NDRG4 colocalized at the cell cor-
tex, in extended cell processes (Figure 2C, inset and intensity pro-
file), and on intracellular, vesicle-like structures (Figure 2D, digital 
zoom and white arrows). In other regions, nonoverlapping distribu-
tion of these proteins was also apparent. Of interest, the proteins 
FIGURE 1: NDRG4 protein interacts with Bves residues 307–316. (A) Exogenously expressed Bves-Myc protein pulled 
down NDRG4-GFP. NDRG4-GFP did not pull down in the absence of Bves-Myc. (B) NDRG4-GFP was pulled down by 
GST-Bves357 (amino acids 115–357), whereas other truncations of GST-Bves357 (amino acids 115 to 218, 275, or 300, 
respectively) or GST-only control failed to pull down NDRG4-GFP. (B′) GFP-vector lysates fail to be pulled down by 
GST-Bves357 or other truncations. (C) In the SPOTs assay, 13-mer synthesized peptides from amino acid 115 to the end 
of the Bves protein were fused to a cellulose membrane, with 10–amino acid overlap between adjacent peptides. 
GFP-NDRG4 lysate binds to three consecutive Bves peptides on the cellulose membrane, peptides 63–65 (depicted in 
grid overlay), corresponding to Bves residues 307–316: HHFLRGSSST. (D) A domain from Bves residues 292–331, 
containing the Bv/N4-MBD identified in C, is cloned into the myc-3tag vector. n ≥ 4 assays/experiment.
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proteins (Figure 3, A and B). The average band intensity from three 
blots normalized to cyclophilin indicated that the NDRG4 (Figure 
3A′), Bves (Figure 3B′), and pooled oligo (Figure 3, A′ and B′) deple-
tions were significantly and highly reduced relative to standard con-
trol treatments. In addition, Bv/N4-MBD was tested for interference 
with native Bves and NDRG4 binding. Bv/N4-MBD proteins overex-
pressed in epicardial cells exhibited cytoplasmic localization, con-
sistent with native NDRG4 (Figure 3C compared with Figure 2D). 
Single-pixel confocal analysis of all z-planes revealed that Bv/N4-
MBD and native NDRG4 proteins colocalized in epicardial cells 
(Figure 3, D, cells, and E, single-pixel colocalization). Analysis of 
Bves and NDRG4 interaction regulates epicardial cell 
movement
To ascertain whether Bves and/or NDRG4 regulated cell motility in 
epicardial cells, we disrupted protein expression by two indepen-
dent assays: 1) delivery of small interfering RNA (siRNA) to deplete 
cells of either/both proteins, and 2) application of the Bves/NDRG4 
minimal-binding domain construct (Bv/N4-MBD) to specifically 
disrupt the Bves/NDRG4 interaction. Both NDRG4 (Figure 3A) and 
Bves (Figure 3B) oligos depleted each protein, whereas partner pro-
tein expression was not significantly affected (Figure 3, A–B′). As 
expected, pooling NDRG4 and Bves oligos visibly depleted both 
FIGURE 2: Bves and NDRG4 colocalize and interact in mammalian epicardial cells. (A) Bves and NDRG4 colocalize in 
trabecular cardiomyocytes (merge) and epicardial cells (box denotes digitally zoom inset) from E14.5 murine heart 
sections. Scale, 75 μm. (B) A column cross-linked to Bves antibody pulls down NDRG4 protein from epicardial cell lysate, 
whereas another antibody, MF-20, does not; n ≥ 4 pull downs. (C) Epicardial cells at low confluence exhibit Bves and 
NDRG4 colocalization in plasma membrane protrusions (box denotes digitally zoomed inset); graph depicts 
colocalization in confocal images (D). Punctate, vesicle-like colocalization of Bves and NDRG4 are apparent in high-
magnification confocal images of epicardial cells with motile morphology (box denotes digitally zoomed inset; white 
arrows demarcate vesicle-like structure). (E) Bves/NDRG4 fail to colocalize in confocal images of epicardial cell sheets 
(box denotes inset of cell borders). Epi, epicardium; Myo, myocardium; optical slices, 1 AU. Colocalizations quantified by 
ImageJ intensity profiling, Bar, 10 μm or as marked.
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migration of epicardial cells back to control levels (Figure 3G). Of 
importance, transient coexpression of the Bves truncation mutant 
(myc-Bves275) lacking the NDRG4 interaction domain failed to res-
cue the number of randomly migrating cells (Figure 3G). Finally, 
overexpression of two separate Bv/N4-MBD plasmid clones signifi-
cantly increased transwell migration compared with controls (Figure 
3H), corroborating gene depletion studies. Taken together, these 
data demonstrate that Bves and NDRG4 interaction regulates undi-
rected migration in epicardial cells.
Bves/NDRG4 interaction regulates epicardial cell directional 
persistence and fibronectin trafficking
Disruption of Bves/NDRG4 interaction increases random cell move-
ment, but the underlying molecular and cellular mechanisms are not 
understood. To observe the specific motility defect impaired with 
loss of Bves and/or NDRG4 function, we treated epicardial cells with 
Bves and/or NDRG4, or standard control (SC) siRNA, plated on glass 
in complete medium, and imaged for 2 h at a frame rate of 1/min 
(SC, Supplemental Movie S1; Bves/NDRG4 depleted, Supplemental 
Movie S2; Bves depleted, Supplemental Movie S3; NDRG4 de-
pleted, Supplemental Movie S4). Distance traveled, velocity, and di-
rectional persistence were quantified using ImageJ manual tracking 
analysis (Figure 4, A and B; demarcated by colored lines overlaid on 
movies and stills). Depleted cells exhibited significantly increased ve-
locity and path lengths as compared with controls (Figure 4C and 
average band intensities indicated that Bv/N4-MBD pulled down 
NDRG4-GFP significantly more than GFP-vector controls, despite 
higher expression of GFP-vector per 25 μg of Cos7 lysate (Supple-
mental Figure S2, A and A′; compare cyclophilin loading control to 
GFP expression in lysate). In addition, overexpression of Bv/N4-
MBD interfered with the native interaction of Bves and NDRG4 
protein as assessed by endogenous pull-down assay (Supplemental 
Figure S2B). Together these data demonstrate that Bves and 
NDRG4 protein levels can be significantly and predictably reduced 
with siRNA constructs. In addition, overexpressed Bv/N4-MBD 
interacts with native NDRG4 and interferes with endogenous Bves/
NDRG4 binding.
With successful depletion of protein levels, we assayed whether 
loss of Bves and/or NDRG4 affected epicardial cell migration. Knock-
down cells were placed within a modified Boyden chamber in which 
serum chemoattractant was homogeneously distributed on both 
sides of the filter to promote random motility. siRNA depletion of 
Bves or NDRG4 significantly increased random movement of epicar-
dial cells (Figure 3F). This phenotype was rescued by stable coex-
pression of Bves or NDRG4 DNA lacking the 3′-untranslated region 
(3′UTR) oligonucleotide target sequences (Figure 3F). Next we de-
termined whether the Bves/NDRG4 minimal-binding domain regu-
lates undirected epicardial cell movements. First, we expressed Bves 
siRNAs as in Figure 3F to elevate random migration. Transient coex-
pression of Bves full-length plasmid completely rescued undirected 
FIGURE 3: The Bves and NDRG4 interaction regulates epicardial cell movement. 3′UTR targeting NDRG4 and Bves 
oligos specifically reduce protein levels of each gene, respectively (A, B). Cyclophilin blots are protein loading controls 
(α-cyclophilin). (A′) Densitometry analysis of three blots demonstrates significant depletion of NDRG4 from NDRG4 and 
Bves + NDRG4 siRNA–treated epicardial cells (graphs relative to SC levels; p < 0.05; NS, not significant). (B′) Significant 
depletion of Bves is demonstrated from three blots in Bves and Bves + NDRG4 siRNA–treated epicardial cells 
(*p < 0.05; NS, not significant). (C) Overexpressed Bv/N4-MBD localizes in cytoplasmic puncta in epicardial cells. Bar, 
10 μm. (D) Single-pixel colocalization of the Bv/N4-MBD construct (green) with native NDRG4 protein (red) in multiple 
Z-planes is (E) demarcated by white pixels (0.5-μm optical slices; bar, 10 μm). (F) Random epicardial transwell migration 
is elevated with Bves/NDRG4 siRNA treatment and rescued by stable overexpression of each gene. (G) Expression of 
Bves-full length plasmid (Myc-BvFL) rescues transwell migration of epicardial cells expressing Bves siRNA, whereas 
expression of a Bves plasmid truncated at residue 275 (Myc-Bv275) does not. (H) Overexpression of two clones of the 
Bv/N4-MBD construct (Bv/N4-MBD1 and 2, respectively) induces an increase in random cell motility due to disruption of 
Bves–NDRG4 interaction. For F–H, n ≥ 3 assays/experiment, *p ≤ 0.05, **p ≤ 0.0003, from SCs.
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and defective vesicular trafficking, we tested whether fibronectin ac-
cumulated intracellularly in Bves- and/or NDRG4-depleted cells.
Immunofluorescence confocal microscopy revealed that large 
fibronectin-positive structures are indeed present in the cytoplasm 
of these cells (Figure 5A; DiI lipophilic dye labels cell borders). 
Quantification by object analysis using ImageJ revealed that Bves- 
and/or NDRG4-depleted cells exhibited a twofold to threefold in-
crease in the number, mean area, and intensity of fibronectin-posi-
tive structures compared with controls (Figure 5, B and C). Similarly, 
application of Bv/N4-MBD (compared with GFP-vector transfection 
control) induced retention of Dylight-550 labeled fibronectin, which 
was supplemented in fibronectin-depleted medium (Figure 5D). 
The size, number, and intensity of these internal fibronectin-positive 
compartments mirrored what was seen with endogenous fibronec-
tin retention after siRNA knockdown (Figure 5B). Immunostaining 
demonstrated that fibronectin accumulated in LAMP2-positive en-
dosomal/lysosomal compartments (Figure 5E) and small Rab11a-
positive endosomes (Figure 5F). Together these data demonstrate 
that disruption of Bves and NDRG4 function impairs endocytic traf-
ficking of fibronectin.
Fibronectin substrate rescues Bves and NDRG4 migration 
and trafficking defects
It was previously demonstrated that migration defects in cells 
deficient in autocrine ECM production can be fully rescued by 
Supplemental Figure S3A). An overlay of the progressive paths of 10 
representative cells visually demonstrates that disruption of Bves 
and/or NDRG4 function randomizes cell movement (Figure 4D). Of 
interest, quantitation of the data revealed that Bves-depleted, 
NDRG4-depleted, or codepleted cells had strikingly poor directional 
persistence (Figure 4E). Directional persistence is calculated by divid-
ing the total displacement by the distance traveled; it is measured on 
a scale of 0 to 1, where 0 is random movement and 1 is movement in 
a straight line (Harms et al., 2005). Treatment of epicardial cells with 
Bv/N4-MBD also significantly impaired directional persistence, mim-
icking siRNA knockdown results. Distance traveled and velocity were 
also statistically significantly increased, albeit more modestly than 
with protein deletion (Supplemental Figure S3, C and D).
In addition to impaired cell movements, time-lapse differential 
interference contrast imaging demonstrated that Bves- and/or 
NDRG4-depleted cells accumulated large cytoplasmic vacuoles 
(Figure 4B, yellow arrow) that originated at the plasma membrane 
and rapidly traveled toward the nucleus (exemplified in Supplemen-
tal Movies S2 and S3). Because vesicular enlargement is generally 
associated with membrane-trafficking defects (Neufeld et al., 2004), 
this finding suggested that presence of Bves and NDRG4 proteins is 
necessary for regulation of vesicular transport. Our previous data 
demonstrate that vesicular trafficking of exogenous fibronectin 
present in the environment influences cell movement (Sung et al., 
2011). Given the current phenotype of randomized cell movement 
FIGURE 4: Bves and NDRG4 coregulate epicardial cell directional persistence and fibronectin trafficking. Lines overlaid 
on time-lapse movies using manual tracking analysis (ImageJ) demarcate cell movements per minute. (A) The migration 
pattern of epicardial cells treated with SC siRNAs is directional. (B) The migration pattern of Bves/NDRG4 co-
knockdown epicardial cells shows increased distance traveled and lacks directionality compared with controls. Cells also 
retain large cytoplasmic vacuoles (yellow arrow). (C) Bves and/or NDRG4 knockdown causes significantly accelerated 
cell movement speed and increased distance traveled. (D) An overlay of 10 representative tracks of cells illustrates the 
randomized cell movements due to Bves and/or NDRG4depletion. Scale bars, 20 μm; n ≥ 40 cells/condition. 
(E) Directional persistence is highly impaired in Bves- and/or NDRG4-depleted epicardial cells (1 = highly directional, 
0 = random); **p ≤ 0.001.
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and codepleted cells were plated on glass coverslips coated 
with 10 μg/ml fibronectin and assayed by live imaging as in 
Figure 4 (SC, Supplemental Movie S5; Bves/NDRG4 depleted, 
supplying high concentrations of exogenous ECM substrate (Sung 
et al., 2011). Thus, to determine whether Bves and NDRG4 regu-
late fibronectin recycling, Bves-depleted, NDRG4-depleted, 
FIGURE 5: Bves/NDRG4-depleted cells contain large fibronectin-positive objects in late endosomal/lysosomal and 
recycling endosome compartments. (A) Endogenous fibronectin-positive cytoplasmic objects are apparent in Bves- and/
or NDRG4-depleted epicardial cells (DiI, red; fibronectin antibody, green). (B, C) Objects were measured using ImageJ 
particle analysis (top, original image; bottom, included particles). Bves- and/or NDRG4-depleted cells have significantly 
more fibronectin-positive objects that are larger with stronger fluorescence intensity compared with SC. (D) Bv/N4-MBD 
epicardial cells demonstrate increased number of internalized cytoplasmic DyLight-fibronectin 550 granules that are 
larger, with stronger fluorescence intensity compared with controls, *p ≤ 0.001, **p ≤ 0.0001, from respective control 
cells. (E) Bves/NDRG4-depleted epicardial cells exhibit fibronectin-positive objects (green) traffic in late endosomal/
lysosomal compartments labeled with Lamp2 (red) in. Bar, 5 μm. (F) Fibronectin-positive objects (green) are also 
apparent in recycling endosomes labeled with Rab11a (red; box denotes inset) in these cells. Scale bars, 10 μm unless 
otherwise indicated, n ≥ 50 cells/condition; optical slices, 1 AU.
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Bves and NDRG4 regulate autocrine ECM deposition
Our data suggest that Bves and NDRG4 regulate cell movement 
through fibronectin recycling. To test the functionality of ECM pro-
duced by control and Bves/NDRG4-depleted cells, we isolated auto-
crine-produced, cell-free ECM from each of the cell types by remov-
ing confluent cell monolayers with 20 mM ammonium hydroxide 
(Sung et al., 2011). Fresh Bves/NDRG4-depleted or SC-treated cells 
were then plated on these cell-free matrices and monitored for direc-
tional persistence for 2 h. On ECM produced by control cells, newly 
plated epicardial cells moved directionally whether cells were treated 
with SC or Bves/NDRG4 siRNA (Figure 7, A and A′; SC cells, Supple-
mental Movie S9; Bves/NDRG4-depleted cells, Supplemental Movie 
S10). This is similar to results obtained from cells plated on exoge-
nous fibronectin substrates (Figure 6B). In contrast, only control cells 
moved in a directionally persistent manner on ECM produced by 
Bves/NDRG4-depleted cells (Figure 7, A and A′; SC cells, Supple-
mental Movie S11; Bves/NDRG4-depleted cells, Supplemental 
Movie S12), whereas Bves/NDRG4-depleted cells moved randomly, 
phenocopying their behavior on matrix-free glass (Figure 4B).
In this experiment, soluble fibronectin was present in the me-
dium in both experimental conditions. Thus a possible explanation 
for the efficient migration of control cells on matrix produced by 
Bves/NDRG4-depleted cells is that control cells can dynamically 
Supplemental Movie S6; Bves depleted, Supplemental Movie S7; 
NDRG4 depleted, Supplemental Movie S8). Of interest, Bves- 
and/or NDRG4-depleted cells migrated with strong directional 
persistence equivalent to or improved beyond SC levels when 
plated on a fibronectin substrate, unlike the randomized move-
ments observed on glass (Figure 6, C and E, and Supplemental 
Figure S3B). In addition, Bv/N4-MBD was applied to epicardial 
cells, and migration was assessed on fibronectin substrate. Similar 
to gene-depletion studies, Bv/N4-MBD–induced directional per-
sistence defects were completely rescued by fibronectin substrate 
(Supplemental Figure S3C). Intriguingly, distance and velocity 
measurements in NDRG4-depleted and codepleted cells were 
only partially rescued by plating on exogenous fibronectin, 
whereas migration distance and velocities were not rescued at all 
in Bv/N4-MBD–expressing cells (Figures 6C and Supplemental 
Figure S3D). These data suggest that secretion of matrix depen-
dent on Bves, and NDRG4 is specifically responsible for direc-
tional persistence, whereas other migration characteristics either 
may depend on different secretory cargo or require alternative 
Bves and/or NDRG4 functions. Overall, exogenously applied fi-
bronectin matrix rescued directionality, suggesting that a key 
function of the Bves–NDRG4 interaction may be to regulate fi-
bronectin recycling to facilitate directional movement.
FIGURE 6: Homogeneous fibronectin substrate rescues Bves and NDRG4 migration defects. Epicardial cells are imaged 
and tracked as in Figure 4. Highly directional movement of SC-treated (A) epicardial cells is apparent on an evenly 
distributed fibronectin substrate as well as in Bves/NDRG4-codepleted cells (B) over a 2-h time course. (C) Migration 
distance and velocity of Bves- and/or NDRG4-depleted epicardial cells are only partially restored on fibronectin 
substrate. (D) Epicardial cells exhibit highly directional movement on fibronectin substrates regardless of siRNA 
treatment condition, as represented by 10 paths stacked together. Scale bars, 20 μm. *p ≤ 0.05; n ≥ 44 cells/condition; 
NS, not significant. (E) Bves-depleted cell directionality is fully rescued by fibronectin substrates as calculated by 
directional persistence quantifications. NDRG4/Bves codepleted cells exhibit improved directionality compared with 
controls. n = 3 experiments/condition; *p < 0.05.
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a directionally persistent manner on matrix 
produced by SC cells, as dynamic ECM se-
cretion of internalized fibronectin was un-
necessary on a well-formed matrix (Figure 
7B). Conversely, in the absence of soluble 
fibronectin, control cells were unable to mi-
grate persistently when plated on matrix 
produced in the absence of Bves and 
NDRG4 function (Figure 7, B and B′; SC cells 
on SC ECM, Supplemental Movie S13; SC 
cells on Bves/NDRG4-depleted ECM, Sup-
plemental Movie S14). Thus the presence 
of fibronectin in the medium is required for 
control cells to overcome deficiencies in ma-
trix produced by Bves/NDRG4-depleted 
cells (compare Figure 7, A′ and B′). These 
data demonstrate that autocrine ECM de-
position is necessary for persistent epicar-
dial cell movement. Loss of cellular Bves 
and NDRG4 function disrupts this process.
We next directly tested whether Bves 
and NDRG4 regulate fibronectin internaliza-
tion and/or deposition. Biotin-labeled fi-
bronectin was added to the medium of con-
trol and Bves/NDRG4-depleted epicardial 
cell sheets after 24 h of culture in fibronec-
tin-free medium. After 18 h, cells were re-
moved from the plate as before, and the 
amount of biotin-labeled fibronectin present 
in the resulting autocrine-deposited ECM 
was quantified by streptavidin–horseradish 
peroxidase (HRP) enzyme-linked immuno-
sorbent assay. Absorbance measurements 
demonstrated that Bves/NDRG4-depleted 
epicardial cells deposited fourfold less fi-
bronectin than controls (Figure 7C). To visu-
alize directly whether epicardial cells inter-
nalized fibronectin, we pulsed cells grown in 
fibronectin-depleted medium with DyLight 
550-labeled fibronectin for 1 h (Figure 7, D 
and E). Under these conditions, internalized 
DyLight 550 fibronectin localized to vesicu-
lar compartments and colabeled with Bves 
and NDRG4 (Figure 7, D and E, respectively). 
Taken collectively, our studies demonstrate 
that internalization of soluble fibronectin 
into vesicles proceeds in the absence of 
Bves and NDRG4. Resecretion of this ECM 
component depends on their function in 
transport vesicles to promote directionally 
persistent migration.
Bves and NDRG4 mediate plasma 
membrane fusion of endosomal 
compartments
The present data demonstrate that Bves 
and NDRG4 mediate a critical cellular be-
havior, autocrine fibronectin recycling. In addition, Bves was previ-
ously implicated in exocytosis of many other cargoes (Hager and 
Bader, 2009). Because Bves is an integral plasma membrane pro-
tein, a likely mechanism regulated by Bves is vesicle docking, po-
tentially via its binding partner VAMP3. Thus we tested whether 
internalize and resecrete fibronectin present in the medium for use 
as a motility substrate. To test this hypothesis, we replated cells on 
matrix deposited by control or Bves/NDRG4-depleted cells. Motility 
assays were then performed in medium depleted of fibronectin 
(prepared as described by Danen, 2002). SC-treated cells moved in 
FIGURE 7: Bves and NDRG4 coregulate fibronectin deposition. Matrix deposition is probed using 
a cell-free ECM assay, which removes cells but keeps the ECM. Migration of newly plated cells is 
then tracked as in Figures 4 and 6 on previously produced ECM to test the function of residual 
matrix. (A) On control-produced ECM, control and Bves/NDRG4-depleted epicardial cells move 
directionally (A′). On Bves/NDRG4-depleted ECM, control cells move directionally while Bves/
NDRG4-depleted cells have poor directional persistence (A′; *p < 0.01). (B) Control epicardial cells 
fed medium lacking fibronectin move directionally on control ECM and fail to move directionally 
(B′) on Bves/NDRG4-depleted ECM (*p < 0.01). This differs from A, in which controls overcome 
Bves/NDRG4-depleted ECM deficiency. (C) Biotin-labeled fibronectin deposition onto a glass 
surface is impaired in Bves/NDRG4-depleted cells compared with controls (n = 7 assays, 
**p < 0.001). (D, E) Epicardial cells internalize DyLight-550–labeled fibronectin (DyLight-FN) after 
a 1-h pulse. Endogenous Bves (D) and NDRG4 (E) colocalize with DyLight-FN on vesicular 
structures; boxes in merge denote digitally zoomed region. Optical slices, 1 AU; scale, 10 μm; 
n ≥ 50 cells/assay.
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plasma membrane). In control cells, visual-
ized best in real-time movies, VAMP3-GFP 
vesicles were numerous at the basal surface 
(Figure 8, A–A′′; SC, Supplemental Movie 
S15; quantification in Figure 8C). Alterna-
tively, Bves/NDRG4-depleted cells exhib-
ited significantly decreased presence of 
VAMP3-GFP vesicles in this region (Figure 
8, B–B′′ and C; Bves/NDRG4 depleted, 
Supplemental Movie S15). Similar experi-
ments, in which epicardial cells were 
cotransfected with VAMP3-GFP and vector 
control or Bv/N4-MBD plasmids, demon-
strated significant loss of VAMP3-GFP at 
the basal surface, with disruption of Bves/
NDRG4 binding (Figure 8D). In addition, 
quantification of dwell times (separated 
into 1-s bins, monitored up to 7 s) indicated 
that many VAMP3-GFP vesicles resided at 
the basal surface for prolonged periods in 
controls, which is indicative of membrane 
docking (Malarkey and Parpura, 2011). Of 
importance, the dwell times of vesicles in 
Bves/NDRG4-depleted cells were signifi-
cantly reduced compared with controls 
(between 1 and 3 s, with the majority ≤2 s). 
This demonstrated that vesicles in Bves/
NDRG4-depleted cells failed to dock at the 
cell surface (Figure 8E). Similarly, cotrans-
fection of Bv/N4-MBD and VAMP3-GFP in 
epicardial cells led to impaired dwell times 
compared with Myc-3tag vector–trans-
fected controls (most resided at membrane 
between 1 and 2 s; Figure 8F). Taken to-
gether, these data indicate that the Bves/
NDRG4 interaction mediates docking of 
VAMP3-labeled vesicles.
DISCUSSION
Here we identify a critical protein/protein 
interaction between Bves and NDRG4 that 
influences epicardial cell movements. Care-
ful characterization of Bves/NDRG4 inter-
action using multiple, complementary 
methodologies revealed an overlapping 
function. Bves and NDRG regulate direc-
tional persistence in migratory cells to me-
diate directionality of these movements. 
Cell/matrix recombination techniques de-
termined that Bves and NDRG4 facilitate 
directional movement by regulating auto-
crine fibronectin recycling as a motility sub-
strate. Finally, TIRF microscopy revealed 
that Bves/NDRG4 interaction regulates fu-
sion of cell surface–bound vesicles. To-
gether these findings explain how delivery 
of plasma membrane–bound and secreted 
cargoes are impaired with Bves loss of function. We propose that 
the Bves complex is a pivotal regulator of cell migration and adhe-
sion by mediating cell surface cargo delivery of functional compo-
nents. In this way, Bves may have broad influence on many cellular 
behaviors affecting development, repair, and cancer.
VAMP3 vesicle docking requires Bves and NDRG4. Control or 
Bves/NDRG4-depleted epicardial cells were transfected with 
VAMP3-GFP. Movement and docking of fluorescent vesicles was 
monitored at the basal cell surface with TIRF microscopy (Figure 
8, A–B′′; black spots indicate VAMP3-GFP–labeled vesicles at 
FIGURE 8: Bves/NDRG4 interaction is required for long-term exocytic vesicle docking at the 
plasma membrane. Three consecutive time-lapse TIRF microscopy images of control (A–A′′) and 
Bves/NDRG4 (B–B′′) knockdown cells transfected with Vamp3-GFP (black dots). Control cells 
contain numerous VAMP3 vesicles (C; yellow, 17.9) at the membrane over the time course, 
whereas Bves/NDRG4 (C; blue, 2.3) knockdown cells contain significantly fewer (**p ≤ 0.0001) 
average vesicles per movie frame. Similarly, vector control–transfected cells contain significantly 
more vesicles per frame than Bves/NDRG4-treated cells (D; yellow, 20.6; blue, 2.6; **p ≤ 0.0001). 
Quantification of dwell time separated into 1-s bins (E) reveals that vesicles in Bves/NDRG4-
knockdown cells do not reside at the membrane as long as VAMP3 vesicles do in SC-treated 
cells. Dwell-time quantifications of cells coexpressing VAMP3-GFP and control myc-3tag vector 
(F, yellow) or Bv/N4-MBD (blue) plasmids indicate that vesicles do not reside at the membrane 
as long in the presence of Bv/N4-MBD; n ≥ 15 movies per condition.
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Although NDRG4 is known to affect cell migration in cancer and 
other cell lines (Nishimoto et al., 2003; Melotte et al., 2009; Wang 
and Hill, 2009) and delivery of intracerebral neurotrophic factors in 
mice (Yamamoto et al., 2011), the present study is the first to identify 
the mechanism by which NDRG4 directs this behavior. Collective 
data suggest that NDRG4 regulates trafficking in multiple contexts. 
Of interest, other NDRG-family proteins also participate in subcel-
lular trafficking. NDRG1 is required for E-cadherin recycling, as well 
as myelin sheath maintenance and APO AI/AII lipid trafficking in 
Schwann cells (Hunter et al., 2005; Berger et al., 2006; Kachhap 
et al., 2007; King et al., 2011). NDRG2 is necessary for interleukin-10 
secretion (Choi et al., 2010). A caveat of the present study is that 
NDRG1–3 may also participate in Bves-dependent fibronectin recy-
cling mechanisms. Thus we speculate that some overlap may exist, 
although other NDRG proteins were not identified in our split-ubiq-
uitin screen. This is an exciting avenue for future research, as it would 
further generalize the Bves trafficking function (Melotte et al., 
2010).
Of interest, NDRG4 binds Bves in a domain that is not present 
in the other Popdc family proteins. The three members of the 
Popeye gene family contain many alternative splice variants for 
each family member and are tissue specifically enriched (Hager 
and Bader, 2009). A diverse array of trafficking events has been 
credited to Popeye gene products. It is possible that Popeye-
family gene products vary in order to facilitate trafficking of differ-
ent binding partners, as needed by the cellular context. Indeed, 
we observed that specifically disrupting Bves/NDRG4 interaction 
was relevant only to cell directionality and not to migration rate/
distance. Because other Bves binding partners such as guanine 
nucleotide exchange factor T (Smith et al., 2008) also regulate cell 
migration, we speculate that the array of splice variants could 
govern individual cellular behaviors by binding to different Bves 
interaction partners.
Fibronectin recycling supports cell directionality
The present data demonstrate that autocrine fibronectin recycling 
supports directionally persistent cell movement. One possible 
explanation for the requirement of ECM in promoting persistent 
motility is that spontaneous cell polarization facilitating cell migra-
tion is frequently unstable. Thus it might be stabilized by adhesion 
formation at the leading edge of cells by newly secreted ECM. Con-
sistent with this idea, Bves inhibition results in lamellipodial and cell 
polarization defects (Hager and Bader, 2009; Hager et al., 2010). At 
lower matrix concentrations or in a complex ECM environment 
(e.g., in vivo), direct deposition of ECM at the leading edge of cells 
might be the most efficient mechanism to stabilize newly formed 
lamellipodia and thus strengthen cell polarization within a brief time 
frame. Bves and NDRG4 have emerged as critical regulators linking 
cell autocrine ECM deposition and directional movement.
Directed cell migration, autocrine ECM deposition, 
and the epicardium
Epicardium produces fibronectin, which is abundant subjacent to its 
epithelial component, and adherence of epicardial integrin recep-
tors to these substrates is critical for coronary artery formation 
(Manasek, 1969; Kalman et al., 1995; Kwee et al., 1995; Yang et al., 
1995; Sengbusch et al., 2002; Nahirney et al., 2003). The present 
study identifies a subcellular trafficking mechanism that facilitates 
fibronectin recycling and links this property to epicardial cell move-
ment. These studies require important follow-up analyses using 
other in vitro cell systems and in vivo models. Yet we propose that 
autocrine fibronectin recycling supports de novo matrix production 
Bves and NDRG4 regulate overlapping cellular behaviors
Multiple independent studies demonstrated that loss of Bves or 
NDRG4 functions results in disruption of cell movement. For exam-
ple, morpholino Bves knockdown impairs lamellipodial formation in 
Xenopus head mesoderm and NIH-3T3 cells (Smith et al., 2008; 
Hager et al., 2010), and expression of antisense NDRG4 RNA inhib-
its neurite outgrowth in PC12 neuronal cell lines (Ohki et al., 2002). 
We determined that Bves is an essential regulator of persistent di-
rectional migration. Depletion of NDRG4 or inhibition of the Bves/
NDRG4 interaction also randomizes cell movement. These findings 
may explain the previously reported errors in morphogenesis and 
wound healing seen with Bves loss of function, where directed cell 
movement is required for gastrulation and wound closure (Ripley 
et al., 2004, 2006). In addition, Bves and NDRG4 are hypermethy-
lated and down-regulated in multiple cancer cell types (Feng et al., 
2008; Melotte et al., 2009; Schilling et al., 2009; Kim et al., 2010; 
Williams et al., 2011), and overexpression of either gene inhibits mi-
gration in related cancers (Melotte et al., 2009; Williams et al., 2011). 
The present data suggest a mechanism through which these gene 
products mediate directed migration in these contexts. Future stud-
ies will identify the specific role(s) for autocrine ECM deposition in 
these diverse in vivo settings.
Bves and NDRG4 are essential for autocrine fibronectin 
recycling
Bves is important in the trafficking of cell/cell and cell/matrix adhe-
sion molecules to the cell surface through interaction with diverse 
binding partners (Hager and Bader, 2009). Here we determined that 
Bves and NDRG4 specifically mediate movement of fibronectin via 
resecretion of endocytosed ECM. The initial uptake of fibronectin is 
not inhibited with loss of Bves or NDRG4 function. Indeed, large fi-
bronectin and LAMP2 (late endosome) and Rab11 (recycling endo-
some) double-positive compartments are found in the cytoplasm of 
Bves- and/or NDRG4-depleted cells. This suggests that Bves and 
NDRG4 function downstream of internalization to promote fibronec-
tin secretion from either late or recycling endosomes. Vesicle fusion 
assays demonstrate that inhibiting Bves/NDRG4 interaction specifi-
cally disrupts VAMP3-positive vesicle docking to the cell surface. 
Furthermore, Bves/NDRG4 disruption results in a reduction in bio-
tin-labeled fibronectin moving from the medium to the insoluble 
matrix. Together these data confirm that cargo delivery requires 
Bves- and NDRG4-mediated vesicle fusion.
Of interest, Bves binds to VAMP3, a vesicle-SNARE protein 
regulating endosome–plasma membrane tethering. Bves does not 
regulate VAMP3 expression levels (Proux-Gillardeaux et al., 2005; 
Hager et al., 2010). This interaction was important for β1-integrin 
trafficking and cell–substrate adhesion. Our new data show that 
both Bves and NDRG4 regulate delivery of VAMP3-labeled vesi-
cles. Collective studies suggest that fibronectin and its integrin 
receptors are recycled in the same endosomal pathway to pro-
mote efficient cell motility. Of note, other groups observed that 
fibronectin bound to α5β1-integrin traffics into late endosomal/
lysosomal compartments, demonstrating that they are cotrafficked 
in other systems (Lobert et al., 2010; Dozynkiewicz et al., 2011). Of 
importance, in studies on cortactin, fibronectin trafficked through 
a late endosomal/lysosomal compartment before exocytosis (Sung 
et al., 2011). Together these data implicate Bves and binding part-
ners as critical components of the fibronectin/β1-integrin exocytic 
mechanism. Although autocrine ECM deposition has been ob-
served in cancer cells, mouse embryonic fibroblasts, and, now, epi-
cardial cell lines, further studies in additional models are required 
to generalize this mechanism.
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LSM150 inverted confocal microscopes, (Carl Zeiss, AG, Jena, 
Germany), and the Delta Vision Platform (Applied Precision, Issaquah, 
WA). All microscopy was done in conjunction with the Cell Imaging 
Shared Resource and Epithelial Biology Center Imaging Resource of 
Vanderbilt University Medical Center.
Split ubiquitin screen
A split ubiquitin screen of murine Bves (NM_024285) against a 
mouse heart library was performed as previously described (Hager 
et al., 2010). Murine NDRG4 transcript A (NM_001195006.1) was 
cloned into the pPR3-N vector and passed all nutrient drop-out se-
lection tests against Bves.
Coimmunoprecipitation, GST pull down, and native 
immunoprecipitation
For coimmunoprecipitation, Bves, cloned into the pCMV-
myc-3tag-4A vector (Agilent Technology, Santa Clara, CA), and 
NDRG4, cloned into the pEGFP-C1 vector (BD Biosciences), 
were exogenously expressed in COS-7 monkey kidney cells 
(ATCC, Manassas, VA) with Lipofectamine 2000 (Invitrogen Life 
Technologies). Lysates were harvested as previously described 
(Hager et al., 2010) and coimmunoprecipitations performed per 
manufacturer’s instructions using Profound c-Myc Tag IP/Co-IP 
Application Set (Thermo Scientific Pierce, Rockford, IL). Bves-
GST truncation pull downs of NDRG4-GFP expressed in COS7 
cells were performed as previously described (Smith et al., 2008). 
For native immunoprecipitation, lysates from 10-cm plates of 
epicardial cells were pooled in M-PER Mammalian Protein 
Extraction Reagent (Thermo Scientific Pierce). Using BS3, 20 μg 
of Bves SB3 or MF-20 antibodies were cross-linked to protein G 
Magnetic Dynabeads (Invitrogen Life Technologies). Dynabeads 
were washed in PBS-T, pH 7.4, and 250 μl of epicardial cell lysate 
was applied and rocked at 4°C for 2 h. Bound proteins were 
eluted in 1× Laemmli buffer and probed with NDRG4 antibodies 
via Western blotting, which was exposed with standard method-
ology (Hager et al., 2010).
SPOTs analysis
A SPOTs membrane designed to the Bves C-terminus (residues 
115–358) was synthesized (Sigma Genosys, Woodlands, TX), with 
each 13-mer peptide having a 10–amino acid overlap with neigh-
boring peptides. NDRG4-EGFP or EGFP vector control lysates 
were exogenously expressed in COS7 cells, and lysates were 
collected using M-PER buffer. Standard bicinchoninic acid assays 
(Thermo Scientific Pierce) determined total protein concentra-
tion, and the SPOTs membrane was prepped and incubated 
in lysate as previously described (Kawaguchi et al., 2008). 
The membrane was incubated with GFP antibodies overnight at 
4°C. Antibody binding was visualized using standard chemilumi-
nescence methodology, and the membrane was regenerated 
using dimethylformamide as previously described (Kramer and 
Schneider-Mergener, 1998). The region surrounding the mini-
mal-binding Bves DNA sequence (BC132044.1; residues 292–
330) was cloned into the pCMV-3tag-4a vector (#240198; Agi-
lent Technologies), and in-frame ligation was confirmed via PCR, 
restriction enzyme dropout of the insert, and sequencing (in 
conjunction with the Vanderbilt University DNA Sequencing 
Facility). Overexpression of 10 μg of two separate clones was 
performed with nucleofection as described later. Expression 
efficiency and colocalization were ascertained by analyzing 
images gathered with the Delta Vision platform and confocal 
microscopes.
to mediate epicardial sheet migration during the complex tissue 
interactions that regulate heart development. Thus, although the 
epicardium is noted for synthesis of ECM components, the mecha-
nism of matrix deposition identified here cannot be overlooked in 




For the assays described here, statistics were performed in Excel 
2011 (Microsoft, Redmond, WA). The error bars represent SEM. 
Standard Student’s t tests were used to determine significance. All 
compared images were equivalently adjusted in Photoshop CS5 
(Adobe, San Jose, CA). For intensity profile quantification, the Im-
ageJ straighten program was used to follow structures at a width of 
five pixels; these pixels were averaged for fluorescence intensity, 
and each channel was plotted together in Excel versus distance 
(micrometers). Progressive paths of epicardial cells after gene 
manipulation were gathered using ImageJ Manual Tracking and 
images were compiled in Photoshop.
Mice
C57Bl/6J mice were kept in 12-h light/dark cycles with ad libitum 
access to standard chow diets and water. Five wild-type dams 
were mated naturally, and plug dates were recorded. Dams were 
killed at embryonic day (E) 14.5, and embryonic hearts of offspring 
were fixed in paraformaldehyde overnight at 4°C. Hearts were 
cryoprotected in a sucrose gradient and then flash frozen in OCT 
(Tissue-Tek Sakura Finetek, Torrance, CA). Frozen hearts were sec-
tioned in 10-μm slices. Hearts were rehydrated in phosphate-buff-
ered saline (PBS), permeabilized with 0.25% PBS-TX100, blocked 
in 10% normal goat serum, and incubated with Bves and NDRG4 
antibodies using standard methodologies. Images were captured 
with Leica TCS-SP5 confocal microscope system (Leica Microsys-
tems, Solms, Germany). All experiments performed with murine 
models followed Institutional Animal Care and Use Committee 
guidelines.
Cell culture, antibodies, immunocytochemistry, 
and immunohistochemistry
Epicardial cell maintenance and processing was standard (Wada 
et al., 2003). The dilutions and manufacturers of the antibodies 
were as follows: anti-Bves SB3 (1:1000; Smith and Bader, 2006), 
anti-NDRG4 (91:500, H00065009-M01; Novus Biologicals, Littleton, 
CO), anti-fibronectin (1:100, SC-9068; Santa Cruz Biotechnology, 
Dallas, TX); anti–glyceraldehyde-3-phosphate dehydrogenase 
(1:500, ab290; Abcam, Cambridge, UK), anti-GFP (1:500, 632375; 
Clonetech Laboratories, Mountain View, CA), anti-Myc (1:200, 
631206; Clonetech), Rab4a/b (1:200, ab13252; Abcam), Rab11a 
(1:500; gift from James Goldenring, Vanderbilt University), EEA1 
(1:200, 610457; BD Biosciences, San Jose, CA), Lamp1 (1:100, 
555798; BD Biosciences), Lamp2 (1:100, ab18538; Abcam), Rab27a 
(1:200, ab55667, Abcam), Alexa Fluor 488, 568, and 647 (1:1000; 
Molecular Probes, Eugene, OR), and 4′,6-diamidino-2-phenylindole 
(1:10,000; Invitrogen Life Technologies; Grand Island, NY). Zenon 
immunoglobulin G labeling kits were used for direct labeling 
(Molecular Probes). Slide preparation for immunocytochemistry was 
standard (Smith and Bader, 2006). For immunohistochemistry, 10-μm 
slices of E14.5 murine hearts were cryosectioned onto charged 
slides. Tissue processing followed standard methodologies (Osler 
et al., 2005; Smith and Bader, 2006). Images were captured with a 
Leica TCS-SP5 confocal microscope (Leica Microsystems), Zeiss 
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Modified Boyden chamber migration assay
Epicardial cells, 3.0 × 105 per experiment, were pelleted for 10 min 
at 1500 RPM in a desktop microcentrifuge and resuspended in 
400 μl of 10% fetal bovine serum (FBS) plus penicillin/streptomycin 
(Life Technologies) in DMEM. The cells were seeded to the basket of 
an 8.0 μM cell culture insert (EMD Millipore, Billerica, MA) and placed 
in 600 μl of the same medium in a 24-well plastic culture dish (BD Bio-
sciences). Cells were incubated for 4 h and processed with standard 
methods (Cross et al., 2011). Phase images were captured on an 
Olympus BX60 microscope and Olympus HKH 027239 camera 
(Olympus, Center Valley, PA).
siRNA knockdown and rescue
Oligos were designed against the 3′UTR of Bves and NDRG4 (Sigma 
Custom Oligos, St. Louis, MO; Supplemental Figure S4). Nucleo-
fection using the Nucleofector II Device (Lonza, Basel, Switzerland) 
was optimized in epicardial cells with a Cell Line Optimization Kit 
(Lonza VCO-1001N). Briefly, 5 × 105 epicardials in nucelofection so-
lution L using nucleofector program A-033 had the highest transfec-
tion efficiency of pMAX-GFP DNA (>70%) and highest viability 
(>80%). Using this protocol, we applied three pooled Bves and/or 
NDRG4 siRNA oligos to epicardial cells at 100 nM each, as well as 
standard control oligos (SIC001; Sigma). Cells were incubated for 
48 h and collected, and protein concentration was normalized to 
expression of the housekeeping gene cyclophilin via Western blot. 
Rescue constructs of Bves and NDRG4 pCMV-Myc-3tag-4 vector 
(Agilent Technology) lacked the siRNA target sequences and were 
stably expressed in epicardial cells via nucleofection, followed by 
3 wk of G418 treatment. Cells were clonally sorted at the Nashville 
VA Medical Center Flow Cytometry Core, expanded, and then as-
sayed with a Boyden chamber, as described earlier. Alternatively, 
Bves full-length or Bves-275 truncation constructs in pCMV-Myc-
3tag-4 vector were transiently cotransfected with siRNA and 
assayed.
Live-imaging assays and analysis
Epicardial cells siRNA depleted for SC, Bves, and/or NDRG4 plas-
mid or treated with GFP-vector and CMV-myc-3tag-4 vector or Bv/
N4-MBD were incubated for 24 h in standard medium and then 
split (5000 cells) into glass-bottom, 35-mm dishes (MatTek, Ashland, 
MA) either uncoated or coated in 10 μg/cm2 fibronectin (F4759; 
Sigma) and incubated for 2 h. To monitor cell movements, differen-
tial interference contrast images were acquired with the DeltaVision 
Platform (Applied Precision) in a temperature-, humidity-, and CO2-
controlled weather station. Images were taken every 60 s with auto-
focus every 30th image. The movies were analyzed for distance, 
velocity, and directional persistence using ImageJ Cell Tracker 
software.
Cell-free ECM assays
Control or Bves/NDRG4-knockdown epicardial cells were seeded 
at 1 × 106 on MatTek dishes or 5 × 105/well of a four-well glass 
chamber slide (Thermo Scientific) and grown to confluence (48 h). 
A cell-free ECM was prepared by applying 20 mM ammonium hy-
droxide to the cells with vigorous rocking for 5 min. The cellular 
debris was washed away with H2O (1×) and PBS (3×) for 5 min 
each, again with vigorous rocking. As a measure of properly pro-
duced ECM, directional persistence was compared between con-
trol cells in complete medium, Bves- and NDRG4-knockdown cells 
in complete medium, and control cells in fibronectin-depleted me-
dium as a negative control, using the described live-cell directional 
persistence assay.
Fibronectin medium depletion and fibronectin 
internalization/deposition assays
To deplete the medium of fibronectin, FBS was purified over a dis-
posable column using Gelatin Sepharose 4B beads (GE Healthcare, 
Fairfield, CT) according to the manufacturer’s protocol and assayed 
for fibronectin depletion via Western blot. Gene-depleted cells 
maintained on glass MatTek dishes were fibronectin starved for 24 h. 
DyLight550 NHS ester- (Thermo Scientific Pierce) or sulfo-NHS-LC-
LC-biotin-labeled fibronectin was incubated at 10 μg/ml for times 
specified in the text and as previously described (Sung et al., 2011). 
Cells were washed 2× with complete medium and 3× with PBS for 
5 min each and then were processed for immunofluorescence as 
before. For DiI labeling experiments, epicardial cells seeded at very 
low confluence on glass or 10 μg/cm2 fibronectin were covered with 
200 μl of Fast DiI (Molecular Probes; 5 μl DiI/1 ml 10% FBS DMEM), 
incubated for 35 min at 37°C, fixed with Formalin for 25 min, and 
processed for antibody labeling as described. For biotin-labeled de-
position experiments, confluent fibronectin-starved cell sheets on 
35-mm plastic dishes (Corning, Corning, NY) were fed biotin-FN for 
48 h and a cell-free assay was performed as described earlier. 
Exposed ECM was conjugated to streptavidin-HRP overnight at 4°C 
(Thermo Scientific). The plates were washed with Tris-buffered sa-
line/Tween 20, pH 8.0, 4× for 10 min each. Cells were exposed to 
TMB substrate (Thermo Scientific Pierce) for 25 min. Reactions were 
stopped with 2 M sulfuric acid and absorbance read per manufac-
turer’s protocol.
Vesicle fusion docking assay
Epicardial cells transfected with standard control siRNA, Bves/
NDRG4 siRNA, CMV-myc3tag-4 vector plasmid, or Bv/N4-MBD 
plasmid and VAMP3-GFP plasmid were plated on MatTek dishes for 
imaging. TIRF microscopy was performed using a Nikon TiE inverted 
microscope (Nikon,Tokyo, Japan) equipped with a Nikon TIRF illu-
minator and a 100×/1.49 numerical aperture objective in combina-
tion with a 1.5× Optivar (75 nm/pixel). Images were acquired at 
30 frames/s using a Hamamatsu ImageEM-CCD camera driven by 
MetaMorph software (Molecular Devices, Sunnyvale, CA). ImageJ 
software was used to quantify the number or particles per movie 
frame, and SpeckleTrackerJ plug-in was used to quantify particle 
dwell times.
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